Aptus Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Aptus Capital Advisors's MDT Position: Q1 2026 in Review
Aptus Capital Advisors increased its Medtronic (MDT) stake by 196% in Q1 2026, buying an estimated $4.68M and bringing the position to 73,769 shares worth $6.39M. The position accounts for 0.05% of the portfolio, ranked #303.
Aptus Capital Advisors first reported a position in MDT in Q2 2020 and has held it in 24 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Aptus Capital Advisors held 73,769 shares of Medtronic worth $6.39M as of Q1 2026.
- Aptus Capital Advisors bought 48,814 Medtronic shares in Q1 2026, an estimated $4.68M.
- Medtronic made up 0.05% of Aptus Capital Advisors's portfolio in Q1 2026, its #303 holding.
- Aptus Capital Advisors first reported a position in Medtronic in Q2 2020 and has held it in 24 quarters since.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.